As of Dec 09
| -1.16 / -0.98%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 131.50, with a high estimate of 170.00 and a low estimate of 101.00. The median estimate represents a +12.47% increase from the last price of 116.92.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.